(Q41406210)

English

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity

scientific article published on January 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

6-O-butyryl-N-acetylmuramyl-L-alanyl-D-isoglutamine N-hydroxy-5-norbornene-2,3-dicarboxylmidyl ester

1 reference

ChEBI release 2020-05-28

author name string

T Hamaoka

1

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Y Takai

2

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

A Kosugi

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Y Mizushima

4

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

J Shima

5

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

T Kusama

6

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

H Fujiwara

7

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

183-188

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the mu

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T cell responses to haptenated cells I. Primary, secondary and long-term cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented induction of tumor-specific resistance by priming with Mycobacterium tuberculosis (TBC) and subsequent immunization with PPD-coupled syngeneic tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of transplantation immunity by dansylated tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H-2-linked genetic control of murine cell-mediated lympholysis to autologous cells modified with high and low concentrations of fluorescein isothiocyanate

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant activity of synthetic N-acetylmuramyl-l-alanyl-d-isoglutamine and related compounds on cell-mediated cytotoxicity in syngeneic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic approach to cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic control of cell-mediated lympholysis to trinitrophenyl (TNP)-modified murine syngeneic cells. I. Expression of Ir gene function at the Cytotoxic precursor and helper cell levels in the response to TNP-H-2 b self

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Target cells for the activity of a synthetic adjuvant: Muramyl dipeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced immunogenicity of chemically-coated syngeneic tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2933141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00205573

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41406210&oldid=2204522790"